Literature DB >> 10436285

The Agency for Health Care Policy and Research smoking cessation clinical practice guideline: basics and beyond.

D E Jorenby1, M C Fiore.   

Abstract

The 1996 Agency for Health Care Policy and Research's Smoking Cessation Clinical Practice Guideline provides a strong empirical foundation for effective smoking cessation interventions in primary care. Screening all patients for tobacco use status at each clinic visit and providing at least brief cessation advice to all smokers can have a significant system-wide effect. Adding additional treatment components, such as pharmacotherapy, problem solving, and social support, can increase quit rates by twofold or more. Information on effective and ineffective treatment components is provided, along with new information published after the release of the Guideline.

Entities:  

Mesh:

Year:  1999        PMID: 10436285     DOI: 10.1016/s0095-4543(05)70115-9

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  4 in total

1.  Tobacco use among adults with disabilities in Massachusetts.

Authors:  Phyllis Brawarsky; D R Brooks; N Wilber; R E Gertz; D Klein Walker
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

Review 2.  Personalized periodontal treatment for the tobacco- and alcohol-using patient.

Authors:  Mark I Ryder; Elizabeth T Couch; Benjamin W Chaffee
Journal:  Periodontol 2000       Date:  2018-10       Impact factor: 7.589

Review 3.  The tobacco-using periodontal patient: role of the dental practitioner in tobacco cessation and periodontal disease management.

Authors:  Benjamin W Chaffee; Elizabeth T Couch; Mark I Ryder
Journal:  Periodontol 2000       Date:  2016-06       Impact factor: 7.589

4.  Teachable moments and missed opportunities for smoking cessation counseling in a hospital emergency department: a mixed-methods study of patient-provider communication.

Authors:  Mara Buchbinder; Rachel Wilbur; Diana Zuskov; Samuel McLean; Betsy Sleath
Journal:  BMC Health Serv Res       Date:  2014-12-20       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.